What is the role of medications in the treatment of acute intermittent porphyria (AIP)?

Updated: Jul 08, 2020
  • Author: Thomas G DeLoughery, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

The goals of pharmacotherapy are to reduce morbidity and to prevent complications. Intravenous hematin is the treatment of choice, both for treatment of severe acute attacks and for prevention of recurrent attacks. [8]  Givosiran, which is given monthly by subcutaneous injection, is a newer treatment option. [15]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!